Merck Serono taps Threshold for Ph III cancer drug
03 February 2012
Eleanor Malone
Please Login to read the full article.
03 February 2012
Eleanor Malone
eleanor.malone@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Erbitux Phase III adds nothing to colon cancer chemo
- Detailed data confirm benefits of Threshold's hypoxia-targeted pancreatic cancer drug
- Merck KGaA's return of TLR9 agonist rights a good deal for Idera
- Idera holds out hope for IMO-2055 after negative Phase II head and neck cancer data
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
